Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Obesity
|
1111 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.070 | 0.714 | 7 | 2001 | 2010 | |||||
Metabolic Syndrome X
|
591 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.050 | 1.000 | 5 | 2005 | 2016 | |||||
Cushing Syndrome
|
9 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.040 | 1.000 | 4 | 2012 | 2020 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.040 | 0.750 | 4 | 2003 | 2015 | |||||
Adrenal Cushing's syndrome
|
9 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.030 | 1.000 | 3 | 2012 | 2020 | |||||
Asthma
|
1536 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.030 | 1.000 | 3 | 2012 | 2016 | |||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.030 | 0.667 | 3 | 2005 | 2013 | |||||
Coronary Artery Disease
|
1577 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.030 | 0.667 | 3 | 2001 | 2013 | |||||
Hypertensive disease
|
1085 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.030 | 0.667 | 3 | 2003 | 2016 | |||||
Multiple Sclerosis
|
1022 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.030 | 1.000 | 3 | 2007 | 2020 | |||||
Cardiovascular Diseases
|
711 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.020 | 1.000 | 2 | 2006 | 2016 | |||||
Chronic active hepatitis
|
34 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.020 | 1.000 | 2 | 2006 | 2009 | |||||
Coronary Arteriosclerosis
|
440 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.020 | 0.500 | 2 | 2001 | 2003 | |||||
Coronary heart disease
|
1178 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.020 | 0.500 | 2 | 2001 | 2003 | |||||
Diabetes Mellitus
|
824 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.020 | 0.500 | 2 | 2001 | 2013 | |||||
Glucocorticoid Receptor Deficiency
|
12 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.020 | 0.500 | 2 | 2006 | 2012 | |||||
Pituitary-dependent Cushing's disease
|
8 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.020 | 0.500 | 2 | 2009 | 2014 | |||||
social stress
|
22 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.020 | 1.000 | 2 | 2004 | 2007 | |||||
21-hydroxylase deficiency
|
28 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
ACTH-Secreting Pituitary Adenoma
|
5 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.010 | 1 | 2009 | 2009 | ||||||
Acute Chest Syndrome
|
135 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.010 | 1 | 2009 | 2009 | ||||||
Acute lymphocytic leukemia
|
222 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Addison Disease
|
13 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Adrenal incidentaloma
|
2 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Autoimmune disease (systemic) NOS
|
3 | 0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 | 0.010 | 1 | 2018 | 2018 |